A Double Blind, Double Dummy, Placebo Controlled Cross Over Study With a Positive Control to Investigate the Effect of a GSK Drug on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects.

Trial Profile

A Double Blind, Double Dummy, Placebo Controlled Cross Over Study With a Positive Control to Investigate the Effect of a GSK Drug on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 06 Jul 2012

At a glance

  • Drugs Raxatrigine (Primary) ; Lidocaine
  • Indications Neuropathic pain
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 12 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 12 Jan 2010 Actual patient number (16) added as reported by ClinicalTrials.gov.
    • 01 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top